Mühlbacher, Axel C. http://orcid.org/0000-0003-4402-9211
de Bekker-Grob, Esther W. http://orcid.org/0000-0001-7645-6168
Rivero-Arias, Oliver http://orcid.org/0000-0003-2233-6544
Levitan, Bennett http://orcid.org/0000-0001-9069-8446
Vass, Caroline http://orcid.org/0000-0002-6385-2812
Funding for this research was provided by:
Hochschule Neubrandenburg
Article History
Accepted: 16 January 2024
First Online: 10 February 2024
Declarations
:
: All authors contributed to the conception and design of the paper. The first draft of the manuscript was written by all authors, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
: Open Access funding enabled and organized by Projekt DEAL. E.W. de Bekker-Grob was funded via the Dutch Research Council (NWO-Talent-Scheme-Vidi-Grant No. 09150171910002).
: Dr. Axel Mühlbacher is an employee of Hochschule Neubrandenburg and GEB Gesellschaft für empirische Beratung mbH. Dr. Esther W. de Bekker-Grob is an employee of Erasmus University Rotterdam. Dr. Oliver Rivero-Arias is an employee of the University of Oxford. Dr. Caroline Vass is an employee of RTI Health Solutions. Dr. Bennett Levitan is an employee of Janssen Research and Development, LLC. He is a stockholder in Johnson & Johnson and a portfolio that at times includes other pharmaceutical and healthcare-related companies.
: Not applicable.